Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
440 12 |
Ultima descărcare din IBN: 2024-01-24 19:08 |
Căutarea după subiecte similare conform CZU |
616.858-036.1-092 (1) |
Neurology. Neuropathology. Nervous system (971) |
SM ISO690:2012 CALDAROV, Anastasia, GAVRILIUC, Olga, ROTARU, Lilia, ANDRUȘCA, Alexandru, FALA, Paula, GAVRILIUC, Mihail. Comorbidități la pacienții cu boala Parkinson.. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2021, nr. 3(71), pp. 30-34. ISSN 1857-0011. DOI: https://doi.org/10.52692/1857-0011.2021.3-71.25 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | |||||||
Numărul 3(71) / 2021 / ISSN 1857-0011 | |||||||
|
|||||||
DOI:https://doi.org/10.52692/1857-0011.2021.3-71.25 | |||||||
CZU: 616.858-036.1-092 | |||||||
Pag. 30-34 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
Un spectru larg de comorbidități a fost asociat cu boala Parkinson, care afectează mai mult de 7 milioane de oameni la nivel mondial. Dovezi emergente indică faptul că bolile cronice, inclusiv diabetul zaharat, depresia, anemia și cancerul, pot fi implicate în patogeneza și progresia BP. Studii epidemiologice recente sugerează că unele dintre aceste comorbidități pot crește riscul de BP și pot preceda apa |
|||||||
Cuvinte-cheie boala Parkinson, simptome non-motorii, anemie, cancer, comorbidități, depresie, diabet, болезнь Паркинсона, немоторные симптомы, анемия, рак, сопутствующие заболевания, депрессия, диабет, Parkinson’s disease, non-motor symptoms, Anemia, cancer, comorbidities, depression, diabetes |
|||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-148303</cfResPublId> <cfResPublDate>2021-11-01</cfResPublDate> <cfVol>71</cfVol> <cfIssue>3</cfIssue> <cfStartPage>30</cfStartPage> <cfISSN>1857-0011</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/148303</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Comorbidități la pacienții cu boala Parkinson.</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>boala Parkinson; simptome non-motorii; anemie; cancer; comorbidități; depresie; diabet; болезнь Паркинсона; немоторные симптомы; анемия; рак; сопутствующие заболевания; депрессия; диабет; Parkinson’s disease; non-motor symptoms; Anemia; cancer; comorbidities; depression; diabetes</cfKeyw> <cfAbstr cfLangCode='RO' cfTrans='o'><p>Un spectru larg de comorbidități a fost asociat cu boala Parkinson, care afectează mai mult de 7 milioane de oameni la nivel mondial. Dovezi emergente indică faptul că bolile cronice, inclusiv diabetul zaharat, depresia, anemia și cancerul, pot fi implicate în patogeneza și progresia BP. Studii epidemiologice recente sugerează că unele dintre aceste comorbidități pot crește riscul de BP și pot preceda apa</p></cfAbstr> <cfAbstr cfLangCode='RU' cfTrans='o'><p>Широкий спектр сопутствующих заболеваний связан с болезнью Паркинсона, которой страдают более 7 миллионов человек во всем мире. Новые данные указывают на то, что хронические заболевания, включая диабет, депрессию, анемию и рак, могут быть вовлечены в патогенез и прогрессирование БП. Недавние эпидемиологические исследования показывают, что некоторые из этих сопутствующих заболеваний могут повышать риск БП и могут предшествовать появлению двигательных симптомов. Однако механизмы, лежащие в основе этих сопутствующих заболеваний, остаются неуловимыми</p></cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'><p>A wide spectrum of comorbidities has been associated with Parkinson’s disease (PD), a progressive neurodegenerative disease that affects more than seven million people worldwide. Emerging evidence indicates that chronic diseases including diabetes, depression, anemia and cancer may be implicated in the pathogenesis and progression of PD. Recent epidemiological studies suggest that some of these comorbidities may increase the risk of BP and may precede the onset of motor symptoms. However, the mechanisms underlying these comorbidities remain elusive.</p></cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-96272</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-46318</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-19818</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-46319</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-51269</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11716</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-148303</cfFedIdId> <cfFedId>10.52692/1857-0011.2021.3-71.25</cfFedId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-96272</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-96272-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFamilyNames>Caldarov</cfFamilyNames> <cfFirstNames>Anastasia</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-46318</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-46318-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFamilyNames>Gavriliuc</cfFamilyNames> <cfFirstNames>Olga</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-19818</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-19818-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFamilyNames>Ротару</cfFamilyNames> <cfFirstNames>Лилия</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-46319</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-46319-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFamilyNames>Andrușca</cfFamilyNames> <cfFirstNames>Alexandru</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-51269</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-51269-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFamilyNames>Fala</cfFamilyNames> <cfFirstNames>Paula</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11716</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11716-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2021-11-01T24:00:00</cfStartDate> <cfFamilyNames>Gavriliuc</cfFamilyNames> <cfFirstNames>Mihail</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>